Contact Lenses Market Size, Share, Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast To 2016 Summary GlobalData's Medical Devices sector report, "Contact Lenses - Medical Devices Pipeline Assessment, 2016" provides an overview of Contact Lenses currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Contact Lenses pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts. Detailed report at: http://www.radiantinsights.com/research/contact-lenses-medicaldevices-pipeline-assessment-2016 *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type. Scope - Extensive coverage of the Contact Lenses under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Contact Lenses and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Reasons To Buy The report enables you to - Formulate significant competitor information, analysis, and insights to improve R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage - Identify and understand important and diverse types of Contact Lenses under development - Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline - In-depth analysis of the product's current stage of development, territory and estimated launch date. Table Of Content: 1 Table of Contents 2 1.1 List of Tables 6 1.2 List of Figures 10 2 Introduction 11 2.1 Contact Lenses Overview 11 3 Products under Development 12 3.1 Contact Lenses - Pipeline Products by Stage of Development 12 3.2 Contact Lenses - Pipeline Products by Segment 13 3.3 Contact Lenses - Pipeline Products by Territory 14 3.4 Contact Lenses - Pipeline Products by Regulatory Path 15 3.5 Contact Lenses - Pipeline Products by Estimated Approval Date 16 3.6 Contact Lenses - Ongoing Clinical Trials 17 To Get Sample Copy of Report visit @ http://www.radiantinsights.com/research/contactlenses-medical-devices-pipeline-assessment-2016#tabs-4 4 Contact Lenses - Pipeline Products under Development by Companies 18 4.1 Contact Lenses Companies - Pipeline Products by Stage of Development 18 4.2 Contact Lenses - Pipeline Products by Stage of Development 20 5 Contact Lenses Companies and Product Overview 23 5.1 Aeon Astron Corporation Company Overview 23 5.1.1 Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview 23 5.2 Alcon, Inc. Company Overview 24 5.2.1 Alcon, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24 5.3 Apeliotus Ophthalmics Company Overview 29 5.3.1 Apeliotus Ophthalmics Pipeline Products & Ongoing Clinical Trials Overview 29 5.4 Auburn University Company Overview 31 5.4.1 Auburn University Pipeline Products & Ongoing Clinical Trials Overview 31 5.5 Axcelon Biopolymers Corp. Company Overview 33 5.5.1 Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview 33 5.6 Bausch & Lomb Incorporated Company Overview 34 5.6.1 Bausch & Lomb Incorporated Pipeline Products & Ongoing Clinical Trials Overview 34 5.7 Body Organ Biomedical Corp. Company Overview 38 5.7.1 Body Organ Biomedical Corp. Pipeline Products & Ongoing Clinical Trials Overview 38 5.8 Children's Hospital Boston Company Overview 40
5.8.1 Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 40 5.9 CooperVision, Inc. Company Overview 42 5.9.1 CooperVision, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42 5.10 EP Global Communications, Inc. Company Overview 43 5.10.1 EP Global Communications, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43 5.11 Euclid Systems Corporation Company Overview 44 5.11.1 Euclid Systems Corporation Pipeline Products & Ongoing Clinical Trials Overview 44 5.12 Eyenovations Company Overview 45 5.12.1 Eyenovations Pipeline Products & Ongoing Clinical Trials Overview 45 5.13 EyeYon Medical Company Overview 46 5.13.1 EyeYon Medical Pipeline Products & Ongoing Clinical Trials Overview 46 5.14 Imperial College London Company Overview 49 5.14.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 49 5.15 Johnson & Johnson Vision Care, Inc. Company Overview 50 5.15.1 Johnson & Johnson Vision Care, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50 5.16 Massachusetts Eye and Ear Infirmary Company Overview 54 5.16.1 Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview 54 Browse All Reports of This Category @ http://www.radiantinsights.com/catalog/medicaldevices 5.17 Novartis AG Company Overview 56 5.17.1 Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 56 5.18 Ocular Dynamics, LLC Company Overview 57 5.18.1 Ocular Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview 57 5.19 Ocutec Limited Company Overview 58 5.19.1 Ocutec Limited Pipeline Products & Ongoing Clinical Trials Overview 58 5.20 Presbia Plc Company Overview 59 5.20.1 Presbia Plc Pipeline Products & Ongoing Clinical Trials Overview 59 5.21 Stanford University Company Overview 62 5.21.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 62 5.22 The Hong Kong University of Science and Technology Company Overview 63 5.22.1 The Hong Kong University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 63 5.23 The University of New South Wales Company Overview 64 5.23.1 The University of New South Wales Pipeline Products & Ongoing Clinical Trials Overview 64 5.24 UltraVision CLPL Company Overview 65 5.24.1 UltraVision CLPL Pipeline Products & Ongoing Clinical Trials Overview 65 5.25 University of California, San Diego Company Overview 66 5.25.1 University of California, San Diego Pipeline Products & Ongoing Clinical Trials Overview 66
5.26 University of Florida Company Overview 68 5.26.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 68 5.27 University of Valencia Company Overview 69 5.27.1 University of Valencia Pipeline Products & Ongoing Clinical Trials Overview 69 5.28 University of Washington Company Overview 71 5.28.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview 71 5.29 University of Western Ontario Company Overview 74 5.29.1 University of Western Ontario Pipeline Products & Ongoing Clinical Trials Overview 74 5.30 Valeant Pharmaceuticals International, Inc. Company Overview 75 5.30.1 Valeant Pharmaceuticals International, Inc. Pipeline Products & Ongoing Clinical Trials Overview 75 5.31 Visioneering Technologies, Inc. Company Overview 95 5.31.1 Visioneering Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 95 5.32 VISTAKON Pharmaceuticals, LLC Company Overview 101 5.32.1 VISTAKON Pharmaceuticals, LLC Pipeline Products & Ongoing Clinical Trials Overview 101 5.33 Yolia Health Company Overview 102 5.33.1 Yolia Health Pipeline Products & Ongoing Clinical Trials Overview 102 Access Full Report: http://www.radiantinsights.com/research/contact-lenses-medicaldevices-pipeline-assessment-2016 6 Contact Lenses- Recent Developments 103 6.1 Mar 03, 2016: The Cooper Companies Announces First Quarter 2016 Results 103 6.2 Mar 01, 2016: First Patients in Presbia Microlens FDA Study Complete 12-Month Postoperative Visits 104 6.3 Feb 19, 2016: Strong growth in revenue and earnings Essilor focused on its 2018 objectives 104 6.4 Feb 12, 2016: Carl Zeiss Meditec Grows, Boosted by Currency Tailwinds / Strongest Growth Once Again in Surgical Ophthalmology 105 6.5 Feb 05, 2016: Briefing Summary of the Analyst/Investor Meeting for the 3rd Quarter Financial Results for the Fiscal Year Ending March 31, 2016 Tokyo, January 29, 2016 106 6.6 Jan 29, 2016: Hoya Reports Third Quarter Results; Record Nine Months Results 109 6.7 Jan 27, 2016: Novartis delivered strong sales growth and core margin expansion (cc[1]) in 2015; announces plans to accelerate growth at Alcon, streamline Group operations 110 6.8 Jan 15, 2016: HOYA Presents Hoya EyeGenius 119 6.9 Dec 16, 2015: AEA Investors to Acquire Majority Stake in 1-800 Contacts from Thomas H. Lee Partners 120 6.10 Dec 16, 2015: Carl Zeiss Meditec increases revenue to â‚Ź 1,040 million / Market shares expanded in a number of markets 120 6.11 Dec 03, 2015: The Cooper Companies Announces Fourth Quarter and Full Year 2015 Results 121 6.12 Nov 10, 2015: Bausch + Lomb Announces 2016 Launch of Bausch + Lomb ULTRA Contact Lenses for Presbyopia 122
6.13 Nov 09, 2015: Unicon Optical to Acquire Taiwan-Based Contact Lenses Company 123 6.14 Nov 06, 2015: Shanghai Conant Optics Plans to Raise up to USD188.6 Million in Private Placement of Shares 123 6.15 Oct 27, 2015: Novartis delivered strong core margin expansion (cc) and continued to strengthen the pipeline in Q3; on track for full-year guidance 123 6.16 Oct 26, 2015: Valeant Pharma Receives FTC Voluntary Request Letter Related To Paragon Holdings Acquisition 130 6.17 Oct 12, 2015: EPGL to Grant CooperVision Exclusive Licenses in Exchange for Royalties and Compensation Agreement by November 6, 2015 131 6.18 Oct 08, 2015: Robins Kaplan LLP Named Co-Lead Counsel in Disposable Contact Lens Antitrust Litigation 131 6.19 Oct 05, 2015: Presbia Introduces Time-Saving Disposable Microlens Inserter 132 6.20 Sep 17, 2015: Presbia Flexivue Microlens Implanted in More Than 1,000 Patients Worldwide 132 6.21 Sep 17, 2015: QSpex Technologies Enters into Agreement with Shanghai Conant Optical 132 About Us Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of Ancillary services such as, research partnerships/ tie-ups and customized research solutions. Media Contact: Michelle Thoras Corporate Sales Specialist, USA Radiant Insights, Inc Phone: 1-415-349-0054 Toll Free: 1-888-202-9519 Email: sales@radiantinsights.com Website: Radiant Insights Visit Our Blog: radiantri.blogspot.com